Immune Cell Application

Aeterna Health’s Immune Cell (iCell) Research focuses on advancing therapeutic approaches that harness the immune system to combat complex diseases. By exploring the underlying mechanisms of immune cell activation, proliferation, and targeting, our research aims to enhance the effectiveness and safety of immune-based therapies.

1. Enhanced Immune Function

   • Investigating how immune cells can be engineered or activated to better detect and eliminate cancer cells, pathogens, and other disease-causing agents.

2. Adjunctive Cancer Therapy

   • Developing methods to integrate immune cell therapies with conventional treatments like chemotherapy and radiation to improve therapeutic outcomes.

3. Chronic Disease Insights

   • Studying immune cell dynamics in autoimmune diseases and other chronic conditions to uncover novel treatment pathways.

1. High-Performance Cell Activity

   • Utilising advanced automated systems to monitor and maintain immune cells at peak activity levels for maximum therapeutic potential.

2. Stringent Quality Standards

   • All research and processes comply with Australian TGA regulations, ensuring clinical-grade quality and safety.

3. Cryopreservation and Viability

   • Employing state-of-the-art -196°C liquid nitrogen systems to preserve immune cells long-term without compromising functionality.

1. Immune System Enhancement

   • Exploring strategies to bolster the body’s immune defences against infections and chronic diseases.

2. Cancer Immunotherapy

   • Investigating ways to improve immune cells’ natural ability to identify and destroy tumours, offering potential advancements in cancer care.

3. Antimicrobial Resistance

   • Researching immune cell applications to address antibiotic-resistant infections, providing innovative solutions to global health challenges.

1. Extensive Clinical Trials

   • Our research is supported by years of clinical data demonstrating the potential efficacy and safety of iCell-based therapies.

2. Institutional Collaborations

   • Aeterna Health works with leading institutions, including La Trobe University and the Hudson Institute of Medical Research, to ensure the highest standards in scientific exploration.

1. CAPRI Cell Advancements

   • Building on CAPRI cell technology, iCell demonstrates improved anti-cancer activity and immune modulation capabilities.

2. Efficient Production Timeline

   • iCells can be prepared within two weeks of sample collection, enabling efficient integration into clinical workflows.

3. Broad Applicability

   • iCell research extends to multiple domains, including cancer, infection control, and immune regulation.